{"id":"W2075148927","doi":"10.1016/j.ejphar.2012.12.019","title":"Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: Two randomised studies","year":2012,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Tolerability; Pharmacokinetics; Placebo; Adverse effect; Cmax; Ipratropium bromide; Anesthesia; Bronchodilator; Tiotropium bromide; Dosing; COPD; Inhalation; Pharmacodynamics; Crossover study; Salmeterol; Pharmacology; Internal medicine; Asthma; Lung; Lung function","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005747657,0.002930027,0.009824803,0.0006627073,0.001128793,0.001774836,0.002408574,0.005931797,0.006739539],"category_scores_gemma":[0.01090168,0.002061668,0.006416576,0.000769473,0.003053203,0.002738249,0.001429176,0.006376473,0.001225092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003333445,"about_ca_system_score_gemma":0.002788999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006525568,"about_ca_topic_score_gemma":0.008286346,"domain_scores_codex":[0.9930935,0.0038436,0.0007471727,0.0009718171,0.0004727145,0.0008712841],"domain_scores_gemma":[0.9897344,0.004739594,0.001838393,0.001127648,0.0006170485,0.001942795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9924872,0.001964381,0.0003678408,0.0002146614,0.0005748143,0.00001474854,0.0000608648,0.00007238021,0.0004188143,0.00001268775,0.00007484429,0.003736782],"study_design_scores_gemma":[0.9140645,0.08149103,0.002774942,0.00004944913,0.0009609872,0.00001702554,0.00004566154,0.000133642,0.000173972,0.00005181063,0.0002042745,0.00003278268],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866922,0.006262416,0.0006231448,0.0005266015,0.0005525161,0.003432522,0.0005244459,0.00008148338,0.001304505],"genre_scores_gemma":[0.9902298,0.002205417,0.001249711,0.0007538728,0.0005155572,0.002964721,0.0006314746,0.00002224559,0.001427247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009824803,"threshold_uncertainty_score":0.03039688,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03060890542434807,"score_gpt":0.3591709965585487,"score_spread":0.3285620911342007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}